BioCardia Reports Q3 2026 Net Loss of $1.8 Million

BioCardia reported a net loss of $1.8 million for the third quarter of 2026, compared with a net loss of $1.5 million a year earlier. Cash and cash equivalents totaled $2.2 million at September 30, 2026, and net cash used in operations was $1.7 million for the quarter. The company also reported pro…